-
1
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
Published 2025-08-01Subjects: “…GEP-NET…”
Get full text
Article -
2
Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
Published 2017-06-01Subjects: Get full text
Article -
3
Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study
Published 2024-11-01Subjects: Get full text
Article